A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...

Ipsen and its fellow French partner Genfit are competing with Intercept and Advanz’s Ocaliva, which was approved in 2016 and ...

Exclusive: Bruce Miller and Warren Littlefield explain how The Handmaid's Tale's sequel show, The Testaments, approaches ...

The most recent trading session ended with Gilead Sciences (GILD) standing at $104.90, reflecting a -0.74% shift from the previouse trading day's closing. This change was narrower than the S&P 500 ...

Sydney Sweeney’s age in The Handmaid’s Tale might surprise you, here is how young she really was while playing Eden.

The Handmaid’s Tale Season 6 finale is just a few weeks away, but fans hoping for a neatly wrapped story to June Osbourne and ...

Hulu's spinoff of 'The Handmaid's Tale' titled 'The Testaments' comes after the original show's sixth and final season ...

As the final season of "The Handmaid's Tale" begins today, we're taking a look back on everything to know about the hit Hulu ...

On The Handmaid's Tale Season 6 Episode 4 Joseph gets a promotion for his reforms while the resistance plans a major assault ...

Wesley Sundquist, a biochemist at University of Utah, and Tomas Cihlar, a virologist at Gilead, a biopharmaceutical company, ...

Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection ...

The resistance against Gilead carries on. Here's what you need to remember before "The Handmaid's Tale" Season 6 starts.